![CardsJC: Screening for Atrial Fibrillation in Older Adults at Primary Care Visits Screening for Atrial Fibrillation in Older Adults at Primary Care Visits - VITAL-AF Trial - Cardionerds Twitter Journal Club CardsJC: Screening for Atrial Fibrillation in Older Adults at Primary Care Visits Screening for Atrial Fibrillation in Older Adults at Primary Care Visits - VITAL-AF Trial - Cardionerds Twitter Journal Club](https://i0.wp.com/www.cardionerds.com/wp-content/uploads/2022/07/image-14.png?resize=731%2C573&ssl=1)
CardsJC: Screening for Atrial Fibrillation in Older Adults at Primary Care Visits Screening for Atrial Fibrillation in Older Adults at Primary Care Visits - VITAL-AF Trial - Cardionerds Twitter Journal Club
![Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial - The Lancet Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/fda982da-6c1f-423a-8489-706f69fdf2f5/gr3.jpg)
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial - The Lancet
![Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial | Journal of the American Heart Association Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/e74d23a9-fa6c-41d5-87bf-97baa04168e1/jah33428-fig-0002.png)
Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial | Journal of the American Heart Association
![First-in-Human Experience and Acute Procedural Outcomes Using a Novel Pulsed Field Ablation System: The PULSED AF Pilot Trial | Circulation: Arrhythmia and Electrophysiology First-in-Human Experience and Acute Procedural Outcomes Using a Novel Pulsed Field Ablation System: The PULSED AF Pilot Trial | Circulation: Arrhythmia and Electrophysiology](https://www.ahajournals.org/cms/asset/0ad41d56-46f5-400f-a9c3-476e5512a32d/circep.121.010168.fig05.jpg)
First-in-Human Experience and Acute Procedural Outcomes Using a Novel Pulsed Field Ablation System: The PULSED AF Pilot Trial | Circulation: Arrhythmia and Electrophysiology
![Dominik Linz on Twitter: "ACTIVE-AF A 6-months intervention (supervised exercise & home-based activity) - Improves AF freedom - reduces AF symptoms - Improves fitness (without changing BP or BMI) -> Be active Dominik Linz on Twitter: "ACTIVE-AF A 6-months intervention (supervised exercise & home-based activity) - Improves AF freedom - reduces AF symptoms - Improves fitness (without changing BP or BMI) -> Be active](https://pbs.twimg.com/media/E90Y2WUXEAY53VK.jpg)
Dominik Linz on Twitter: "ACTIVE-AF A 6-months intervention (supervised exercise & home-based activity) - Improves AF freedom - reduces AF symptoms - Improves fitness (without changing BP or BMI) -> Be active
![Hybrid Convergent Procedure for the Treatment of Persistent and Long-Standing Persistent Atrial Fibrillation | Circulation: Arrhythmia and Electrophysiology Hybrid Convergent Procedure for the Treatment of Persistent and Long-Standing Persistent Atrial Fibrillation | Circulation: Arrhythmia and Electrophysiology](https://www.ahajournals.org/cms/asset/19f79da5-a1ba-40d6-8fd6-0170550b230c/circep.120.009288.fig05.jpg)
Hybrid Convergent Procedure for the Treatment of Persistent and Long-Standing Persistent Atrial Fibrillation | Circulation: Arrhythmia and Electrophysiology
![An Exercise and Physical Activity Program in Patients With Atrial Fibrillation: The ACTIVE-AF Randomized Controlled Trial | JACC: Clinical Electrophysiology An Exercise and Physical Activity Program in Patients With Atrial Fibrillation: The ACTIVE-AF Randomized Controlled Trial | JACC: Clinical Electrophysiology](https://www.jacc.org/cms/asset/b1ae7625-5846-459b-ad78-3f915314b0c0/fx1.jpg)
An Exercise and Physical Activity Program in Patients With Atrial Fibrillation: The ACTIVE-AF Randomized Controlled Trial | JACC: Clinical Electrophysiology
![Dominik Linz on Twitter: "ACTIVE-AF A 6-months intervention (supervised exercise & home-based activity) - Improves AF freedom - reduces AF symptoms - Improves fitness (without changing BP or BMI) -> Be active Dominik Linz on Twitter: "ACTIVE-AF A 6-months intervention (supervised exercise & home-based activity) - Improves AF freedom - reduces AF symptoms - Improves fitness (without changing BP or BMI) -> Be active](https://pbs.twimg.com/media/E90YF61WUAo2v4S.jpg:large)
Dominik Linz on Twitter: "ACTIVE-AF A 6-months intervention (supervised exercise & home-based activity) - Improves AF freedom - reduces AF symptoms - Improves fitness (without changing BP or BMI) -> Be active
![What clinical trials of ablation for atrial fibrillation tell us – and what they do not - Heart Rhythm O2 What clinical trials of ablation for atrial fibrillation tell us – and what they do not - Heart Rhythm O2](https://www.heartrhythmopen.com/cms/asset/7c825798-6b88-45cc-8906-820e0511b448/fx1.jpg)
What clinical trials of ablation for atrial fibrillation tell us – and what they do not - Heart Rhythm O2
![Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial | Nature Medicine Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-022-01979-w/MediaObjects/41591_2022_1979_Fig1_HTML.png)
Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial | Nature Medicine
![AB-453070-2 FLOW-AF: A RANDOMIZED CONTROLLED TRIAL OF ELECTROGRAPHIC FLOW-GUIDED ABLATION IN REDO PATIENTS WITH NON-PAROXYSMAL ATRIAL FIBRILLATION - Heart Rhythm AB-453070-2 FLOW-AF: A RANDOMIZED CONTROLLED TRIAL OF ELECTROGRAPHIC FLOW-GUIDED ABLATION IN REDO PATIENTS WITH NON-PAROXYSMAL ATRIAL FIBRILLATION - Heart Rhythm](https://www.heartrhythmjournal.com/cms/asset/afabdd83-8fe2-4d05-ba2c-c4055d520bfa/fx1.jpg)
AB-453070-2 FLOW-AF: A RANDOMIZED CONTROLLED TRIAL OF ELECTROGRAPHIC FLOW-GUIDED ABLATION IN REDO PATIENTS WITH NON-PAROXYSMAL ATRIAL FIBRILLATION - Heart Rhythm
![EFFICACY AND SAFETY OF EDOXABAN IN PATIENTS WITH ATRIAL FIBRILLATION AND ACTIVE MALIGNANCY: AN ANALYSIS OF ENGAGE AF – TIMI 48 RANDOMIZED CLINICAL TRIAL | Journal of the American College of Cardiology EFFICACY AND SAFETY OF EDOXABAN IN PATIENTS WITH ATRIAL FIBRILLATION AND ACTIVE MALIGNANCY: AN ANALYSIS OF ENGAGE AF – TIMI 48 RANDOMIZED CLINICAL TRIAL | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/c363ec93-fdc4-4bae-9171-046bbab01c7b/s0735-1097(17)33714-2.fp.png)
EFFICACY AND SAFETY OF EDOXABAN IN PATIENTS WITH ATRIAL FIBRILLATION AND ACTIVE MALIGNANCY: AN ANALYSIS OF ENGAGE AF – TIMI 48 RANDOMIZED CLINICAL TRIAL | Journal of the American College of Cardiology
![Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events - ScienceDirect Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0002870305006393-gr1.jpg)
Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events - ScienceDirect
![Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial - The Lancet Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial - The Lancet](https://www.thelancet.com/cms/attachment/2000988592/2003637687/gr1.gif)